| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9911075224903321 |
|
|
Titolo |
Amending the act to provide for the establishment of the Coronado International Memorial, in the State of the Arizona. June 25, 1952. -- Committed to the Committee of the Whole House on the State of the Union and ordered to be printed |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
[Washington, D.C.] : , : [U.S. Government Printing Office], , 1952 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (3 pages) |
|
|
|
|
|
|
Collana |
|
House report / 82nd Congress, 2nd session. House ; ; no. 2298 |
[United States congressional serial set] ; ; [serial no. 11578] |
|
|
|
|
|
|
|
|
Altri autori (Persone) |
|
MurdockJohn Robert <1885-1972> (Democrat (AZ)) |
|
|
|
|
|
|
Soggetti |
|
International relations |
Legislative amendments |
Monuments |
Memorials |
Explorers |
Legislative materials. |
Arizona |
Coronado National Memorial (Ariz.) |
Mexico |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Batch processed record: Metadata reviewed, not verified. Some fields updated by batch processes. |
FDLP item number not assigned. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9911106736203321 |
|
|
Autore |
Vandermeulen Carl |
|
|
Titolo |
Negotiating the Personal in Creative Writing / / Carl Vandermeulen |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Blue Ridge Summit, PA : , : Multilingual Matters, , [2011] |
|
©2011 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-283-22478-X |
9786613224781 |
1-84769-439-X |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (249 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Creative writing -- Study and teaching |
Writing centers |
Creative writing - Study and teaching |
Languages & Literatures |
English |
English Language |
Literature - General |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
Frontmatter -- Contents -- Acknowledgements -- Introduction: Negotiating the Personal and Interpersonal -- Chapter 1. Considering Where We’re Coming From -- Chapter 2. The Workshop: ‘More or Less Unfortunate Misunderstandings’ -- Chapter 3. Reflection and the Dialogic Self -- Chapter 4. Response in Writers’ Groups -- Chapter 5. Teacher Response to Student Writing -- Chapter 6. Negotiating Authority as Teachers, Models, Mentors -- Chapter 7. Problems and Crises in Relationships -- Chapter 8. Resolving Dilemmas of Grading -- Chapter 9. Constructing the Practice and Identity of ‘Writer’ -- References |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book describes an alternative way to teach Creative Writing, one that replaces the silent writer taking criticism and advice from the teacher-led workshop with an active writer who reflects upon and |
|
|
|
|
|
|
|
|
|
|
|
|
|
publically questions the work-in-progress in order to solicit response, from a writers' group as well as from the teacher. Both accompany the writer, first as readers and fellow writers, only later as critics. Because writers ask, they listen, and dialogues with responders become an inner dialogue that guides later writing and revision. But when teachers accompany writers, teaching CW becomes even more a negotiation of the personal because this teacher who is listener and mentor is also a model for some students of the writer and even the person they would like to become - and still the Authority who gives the grades. |
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9911143556803321 |
|
|
Titolo |
Evolution of translational omics : lessons learned and the path forward / / Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy ; Christine M. Micheel, Sharyl J. Nass, and Gilbert S. Omenn, editors ; Institutes of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : National Academies Press, c2012 |
|
|
|
|
|
|
|
ISBN |
|
1-283-63640-9 |
0-309-22419-5 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (338 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
MicheelChristine |
NassSharyl J |
OmennGilbert S |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Genomics - Technology |
Genomics - Data processing |
Genetic translation - Technology |
Biomolecules - Analysis |
Biomolecules - Data processing |
Bioinformatics - Technology |
Biotechnology |
Data mining - Analysis |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
|
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 Omics-Based Clinical Discovery: Science, Technology, and Applications""; ""3 Best Practices for Omics-Based Test Validation Prior to Use for Patient Management Decisions in a Clinical Trial Setting""; ""4 Evaluation of Omics-Based Tests for Clinical Utility and Use""; ""5 Responsible Parties""; ""6 Lessons from the Case Studies""; ""Appendix A: Case Studies"" |
""Appendix B: Gene Expression Based Tests Developed at Duke University and Used in Clinical Trials""""Appendix C: Introduction to Biomarkers""; ""Appendix D: Reporting Guidelines""; ""Appendix E: Committee Member and Staff Biographies""; ""Appendix F: Information Gathering Sessionsand Speakers""; ""Acronyms and Abbreviations""; ""Glossary"" |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Technologies collectively called omics enable simultaneous measurement of an enormous number of biomolecules; for example, genomics investigates thousands of DNA sequences, and proteomics examines large numbers of proteins. Scientists are using these technologies to develop innovative tests to detect disease and to predict a patient's likelihood of responding to specific drugs. Following a recent case involving premature use of omics-based tests in cancer clinical trials at Duke University, the NCI requested that the IOM establish a committee to recommend ways to strengthen omics-based test development and evaluation. This report identifies best practices to enhance development, evaluation, and translation of omics-based tests while simultaneously reinforcing steps to ensure that these tests are appropriately assessed for scientific validity before they are used to guide patient treatment in clinical trials. |
|
|
|
|
|
|
|
| |